TWST · Transaction Mar 30, 2022 · Filed Apr 25, 2022 · $1,001 to $15,000
Twist Bioscience Corp
Veridion Score
BETAMEDIUM CONF · 6 of 6 factors measuredComposite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.
- · Factor breakdown with raw signals
- · Day-over-day delta + driver
- · Factor coverage readout
- · Valuation · hype · market flow
- · Pro Chart event markers
- · Score history + alerts
Why is TWST moving today?
Twist Bioscience Corp is a synthetic biology company that has developed a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's proprietary semiconductor-based manufacturing process synthesizes DNA on silicon rather than traditional plastic plates, enabling the production of high-quality synthetic DNA faster, more affordably, and at scale. This platform overcomes conventional inefficiencies, supports cost-effective, high-throughput synthesis, and allows researchers to accelerate innovation. Geographically, the company operates across the Americas, EMEA, and APAC, deriving the majority of its revenue from the Americas.
Reported fields plus Veridion-computed history. Unsourced tiles are omitted.
TWST overview
Related filings and maps
Congress activity in TWST
TWST · Transaction Mar 2, 2020 · Filed Apr 23, 2020 · $1,001 to $15,000
Twist bioscience Corporation · Transaction Mar 2, 2020 · Filed Apr 23, 2020 · $1,001 to $15,000
TWST contract awards, year to date.
Public federal awards linked to this ticker.
TWST lobbying filings, year to date.
Registered lobbying filings matched to Twist Bioscience Corp.